Will antibody tests for the coronavirus really change everything?

@article{Mallapaty2020WillAT,
  title={Will antibody tests for the coronavirus really change everything?},
  author={Smriti Mallapaty},
  journal={Nature},
  year={2020},
  volume={580},
  pages={571-572}
}
Touted as society’s way out of widespread lockdowns, scientists say the true potential of these rapidly developed tests is still unknown. Touted as society’s way out of widespread lockdowns, scientists say the true potential of these rapidly developed tests is still unknown. 
SARS-CoV-2 pandemic: An overview
Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
TLDR
Examination of antibody titers in sequential samples from serum donors recovering from COVID-19 demonstrated that antibody Titers fall over 3-4 months, which has important implications for convalescent serum collection and seroprevalence studies.
Screening Tests in the Era of COVID-19: Implications for the Plastic Surgeon.
TLDR
New protocols must be implemented to minimize risk by means of appropriate screening of their patients, surgical adjustments to reduce viral transmission in case of undiagnosed infection, and the development of accurate severe acute respiratory syndrome coronavirus 2 tests while awaiting the distribution of an effective vaccine.
Perspectives of Immune Therapy in Coronavirus Disease 2019
TLDR
The improved understanding of the host antiviral responses may help develop safe and effective immunotherapeutic strategies against COVID-19 in the foreseeable future.
COVID-19 detection: Comparison and accuracy of several diagnostic tests
TLDR
It is concluded that the discovery of CRISPR/Cas based in vitro diagnostics will minimize the time limit as well as the cost for COVID-19 detection.
Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity
TLDR
It is shown that, by introducing irrelevant mega peptide pools as negative controls to account for chance cross-reactivity, and by establishing the antigen dose-response characteristic of the T cells, one can clearly discern between cognate T cell memory induced by SARS-CoV-2 infection vs.Cross-reactive T cell responses in individuals who have not been infected with Sars-Cov-2.
Deconvoluting the T cell response to SARS-CoV-2: specificity versus chance- and cognate cross-reactivity
TLDR
It is shown that by introducing irrelevant mega peptide pools as negative controls to account for chance cross-reactivity, and by establishing the antigen dose-response characteristic of the T cells, one can clearly discern between cognate T cell memory induced by SARS-CoV-2 infection vs.Cross-reactive T cell responses in individuals who had not been infected with Sars-Cov-2.
The importance of laboratory medicine in the era of COVID-19 pandemic: a challenge for patients, pediatricians, obstetricians, and clinical pathologists
TLDR
Routine biochemical data in adults with COVID-19 reveal alterations of various tests, including lymphopenia, thrombocytopenia, hypoalbuminemia, and serum elevation of several biomarkers, including D-dimer, ferritin, C-reative protein (CRP), cytokines, which are predictors of adverse outcome and death.
...
1
2
3
4
5
...

References

SHOWING 1-7 OF 7 REFERENCES
Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
  • Juanjuan Zhao, Q. Yuan, Zheng Zhang
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
TLDR
The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients and offer vital clinical information during the course of SARS-CoV-2 infection.
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients
TLDR
It is demonstrated that most PCR-confirmed SARS-CoV-2–infected persons seroconverted by 2 weeks after disease onset, and validated and tested various antigens in different in-house and commercial ELISAs, finding that commercial S1 IgG or IgA ELISA were of lower specificity, and sensitivity varied between the 2 assays; the IgAELISA showed higher sensitivity.
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications
TLDR
The variations of SARS-CoV-2 specific NAbs in recovered COVID-19 patients may raise the concern about the role of NAbs on disease progression and the correlation of NAb titers with age, lymphocyte counts, and blood CRP levels suggested that the interplay between virus and host immune response in coronavirus infections should be further explored.
Evaluation of nine commercial SARS-CoV-2 immunoassays
TLDR
This study evaluated the sensitivity and specificity of nine commercially available serological tests and found that three enzyme-linked immunosorbent assays (ELISAs) and six point-of-care (POC) lateral flow tests showed 100% specificity.
Virological assessment of hospitalized patients with COVID-2019
TLDR
Detailed virological analysis of nine cases of coronavirus disease 2019 (COVID-19) provides proof of active replication of the SARS-CoV-2 virus in tissues of the upper respiratory tract.
Reinfection could not occur in SARS-CoV-2 infected rhesus macaques
TLDR
It is indicated that the primary SARS-CoV-2 infection could protect from subsequent exposures, which have the reference of prognosis of the disease and vital implications for vaccine design.
Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2
A global pandemic of Corona Virus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome CoV-2 (SARS-CoV-2) is ongoing spread. It remains unclear whether the convalescing patients have a